Changes in the 18th Annual Restorative Medicine Conference

It appears that the pandemic emergency will continue through the summer and into the fall, so to protect the safety of all attendees, exhibitors, speakers, and staff, we have decided to make this year's Annual Restorative Medicine Conference an online-only event.

Several changes have been made to the online-only conference so that it is an even better value and greater learning opportunity:

  • Conference registration will now be “two for the price of one.” You now will have the opportunity to add a colleague to your registration at no additional cost.
  • All conference attendees (except those selecting the Peptide Workshop Only registration) will be eligible to earn up to 15 CME credits at this livestream event, plus 10 CME credits as part of the AARM Live Webinar Series August 24-28 from 7-9 PM EST.   Note: CME credits are not available for viewing recordings.
  • Attendees will have access to all recordings, with the exception of the Peptides Workshop. Recordings will be available in your AARM account and are included in conference registration.
    Note: The Peptide Workshop will not be recorded and is only available via livestream.
  • There will be a virtual exhibit hall that will include show specials, product information, and the capability to chat with exhibitor staff.

While it is disappointing that we will not be able to continue our tradition of holding the Annual Restorative Medicine Conference at a resort in a beautiful natural setting, I hope you will join us online, August 20-22, for three days of sharing protocols and other Restorative Medicine knowledge. Our commitment to being an inclusive conference for all health care professionals will continue, even as we are forced to use a virtual format. If you have any questions, please call us toll-free at 866-962-2276 or email us at

In health,

Michaël Friedman ND
Executive Director

2020 Annual Conference – Online Webinar

Registration Now Open!

Sign Up

AARM Webinar Series: August 24-28, 2020, 7:00 - 9:00 pm - online.

Please note that CME credits are not available for watching recordings. NDs may obtain CE credits for watching recordings.

Post-Conference Accredited Courses: Focus on Cardiology, Oncology, Multiple Sclerosis and Thyroid.

Free with the on-site 2020 Annual International Restorative Medicine Conference registration, this package of recorded lectures is valued at $450.  Each recorded lecture will be aired online as part of the AARM Webinar Series August 24-28 from 7:00 - 9:00pm. The American Academy of Family Physicians has approved the AARM webinar series 8/24-8/28 for up to 10 CME Prescribed credits. Physicians must watch the webinars at the designated times to earn credits. Conference attendees will receive a link to access the online webinars after the live conference concludes.

Five CME credits will be made available by reading Journal of Restorative Medicine articles and passing related quizzes.

Faculty members and topics for the Post-Conference webinars are:

Monday, August 24, 2020:  7:00pm – 9:00pm:

The Role of Vascular Biology, Nutrition and Nutraceuticals in the Prevention and Treatment of Hypertension and Cardiovascular Disease


Dr. Houston is tripled boarded in hypertension as an American Society of Hypertension (ASH) specialist and Fellow of the American Society of Hypertension (FASH), Internal Medicine (ABIM) and Anti-aging medicine (ABAARM). He also has a Masters degree in Human Nutrition from the University of Bridgeport, Connecticut and a Masters of Science degree in Functional and Metabolic Medicine from the University of South Florida in Tampa. The Hypertension Institute was founded in 1995 by Dr. Mark Houston, internist and hypertension and cardiovascular specialist, and Dr. Allen Naftilin, cardiologist and hypertension specialist, at St. Thomas West Hospital and St. Thomas West Hospital in Nashville, TN. The Hypertension Institute immediately received national acclaim as one of the leading Institutes in the US for the treatment of hypertension and related cardiovascular disorders. In 2000, the Hypertension Institute was recognized as one of the top Cardiovascular Centers in the Southeast by the Consortium of Southeastern Hypertension Centers (COSEHC).

Course Objectives

-           Review the literature for the underlying mechanisms of hypertension, vascular biology.
-           Evidence-based review of the efficacy of nutrition, lifestyle factors and nutraceuticals in the prevention and treatment of cardiovascular disease.

-           Evidence based review of anti-hypertensive drug – nutrient interactions.

Tuesday, August 25, 2020: 7:00 pm – 9:00pm

Keto Anyone? Timing for Carbohydrate Restriction, Fat Restriction, or Fasting in the Cancer Clinic

Dawn Lemanne, MD, MPH

Dr. Lemanne is a board certified medical oncologist and a leading integrative oncologist. She holds a faculty appointment at the University of Arizona’s Center for Integrative Medicine, is the author of peer-reviewed articles, textbook chapters, and speaks internationally by invitation. Her medical degree was completed at UCSF and she did her clinical oncology fellowship at Stanford University Hospitals. She is the winner of the 2017 American College of Nutrition, Stanley Wallach Award for Advancement of Human Understanding of Nutrition in Cancer. Her private clinic in Oregon attracts patients from around the globe. 

Patients diagnosed with cancer are searching for the “right” diet. Dietary patterns popular among cancer patients at present include the extremely low-carbohydrate ketogenic diet, moderate carbohydrate restriction, “paleo,” low fat, alkaline, and plant-based diets including vegan or raw vegan, and intermittent fasting. Peer-reviewed evidence exists for the efficacy of all of these options, but only under certain circumstances. For example, some animal research on invasive prostate cancer demonstrates that alkalization of drinking water starting in the first few weeks of life prevents development of invasive prostate cancer, whereas this maneuver is less effective if started later in life.

The ketogenic diet, defined as severe carbohydrate restriction leading to measurable blood levels of beta hydroxybutyrate, and fasting may be useful in decreasing the side effects of cancer treatment. Animal studies demonstrate an overall survival benefit in certain cancers, but only when these dietary maneuvers are timed precisely to coincide with treatment. Dr. Lemanne will review the best approaches for dietary interventions, and will clarify the conditions when keto diet or fasting is appropriate, and when it is not.

Goals and Objectives:

  • Understand how timing in the course of a cancer’s evolution determines whether a dietary intervention is effective or harmful.
  • Gain familiarity with the evidence for using moderate carbohydrate restriction in patients with breast and colon cancer.
  • Review the growing body of peer-reviewed literature on the safety and efficacy of the ketogenic diet and fasting in patients with cancer.
  • Demonstrate how the metabolic effects of fasting differ from the metabolic effects of caloric restriction, and how to exploit these differences
  • Review the evidence-based advantages and limitations of the ketogenic diet in cancer therapy

Wednesday, August 26, 2020: 7:00 - 8:00pm

Harnessing Evolution During Cancer Therapy

Dawn Lemanne, MD, MPH

The conventional treatment paradigm oncologists work under advises using the “maximum tolerated dose,” MTD, applied at specific, non-varying frequencies. This is an attempt to kill as many tumor cells as possible while avoiding (sometimes just barely) killing the patient. However, the drawback is competitive release of treatment resistant cells in virtually every case. MTD predictably engenders emergence of treatment-resistance in tumors, and such treatment has now been shown not to prolong survival, but to accelerate death in patients with “incurable” cancers. This lecture will explore recent mathematical modeling and early clinical research that has successfully challenged that approach. This work has resulted in a new treatment paradigm called “adaptive therapy,” under study at Moffitt Cancer Center at the University of South Florida, Arizona State University, and Cleveland Clinic. In cancer treatment, the adaptive therapy approach uses small doses of several antineoplastic pharmaceuticals with varying mechanisms, applied singly or in combination, and at intervals varying based on tumor burden. Integrated into this approach are evidence-based dietary maneuvers, such as carbohydrate restriction, exercise, hyperbaric oxygen therapy, etc. These may require specific timing in tumor evolution and treatment for optimal benefit. The success of the “adaptive therapy” approach is predicted by mathematical models of cancer treatment employing “game theory.” The success of adaptive therapy over MTD has been corroborated in early clinical trials in patients with advanced metastatic prostate cancer and small cell lung cancer.

Goals and Objectives:

  • Discuss the evolutionary reasons behind Peto’s paradox: why some multicellular organisms rarely develop cancer, and why humans are prone to cancer.
  • Discuss the limitations of the “maximum tolerated dose” paradigm when used in treatment of most advanced, incurable metastatic cancers of adults, and contrast it with the “adaptive therapy” model based on a review of research.
  • Review evidence-based support on why adaptive therapy for advanced, metastatic, incurable cancers of adults may be preferred to the older paradigm of “maximum tolerated dose.”
  • Review research on why dietary maneuvers such as carbohydrate restriction (such as the ketogenic diet) or dietary alkalization may be particularly powerful when timed to specific moments in tumor evolution.
  • Understand the limits of “adaptive therapy,” and list the oncologic conditions wherein adaptive therapy should be avoided

Wednesday, August 26, 2020:  8:00-9:00pm

Vitamin D beyond bone health: Primary prevention and therapeutic potentials in the contexts of Multiple Sclerosis and Prostate Cancer.

Reinhold Vieth, Ph.D, F.C.A.C.B.

Dr Reinhold Vieth is a Professor in the Department of Nutritional Sciences, and the Department of Laboratory Medicine and Pathobiology, University of Toronto.  He is an internationally recognized expert on the clinical nutrition of vitamin D as well as its pharmacology and safety.  His research has followed the path of vitamin D from the basic science lab, to bone health and osteoporosis, to breast and prostate cancers.  His current focus includes the role of vitamin D deficiency in gestational diabetes, and multiple sclerosis, including clinical trials of vitamin D treatment.  The American Journal of Clinical Nutrition, lists four of Dr Vieth’s publications among its list of top-25 most read articles.  He is professionally certified as a Clinical Chemist, and at Mount Sinai Hospital in Toronto, is Director of the Bone and Mineral Laboratory, as well as Director of Point of Care Testing.

Course Objectives:

  1. Summarize Evidence Based Research about vitamin D in the context of prevention and treatments for bone health, prostate cancer and multiple sclerosis
  2. Differentiate unresolved issues pertinent to prevention and treatment of these diseases
  3. Address the risk and benefits profiles about the use of vitamin D supplementation/treatment
  4. Explain why it is unrealistic to expect that double blind randomized trials will ever provide evidence that vitamin D can prevent prostate cancer or multiple sclerosis.

Thursday, August 27, 2020: 7:00pm – 9:00pm

Beyond Cholesterol: Predictive, Pro-Active Health

Mimi Guarneri, MD, FACC

Dr. Mimi Guarneri is Board-certified in Cardiovascular Disease, Internal Medicine, Nuclear Cardiology, and Integrative Holistic Medicine. Dr. Guarneri is a Founder and President of The Academy of Integrative Health and Medicine. She serves on the Founding Board of the American Board Physician Specialties in Integrative Medicine, and is a Clinical Associate Professor at University of California, San Diego. An award-winning physician and researcher, she has been recognized for her national leadership in Integrative Medicine by the Bravewell Collaborative, and she served as chair of the Bravewell Clinical Network for Integrative Medicine.  After graduating number one in her class at SUNY Medical Center in New York, Dr. Guarneri began her career at Scripps Clinic as an attending in interventional cardiology, where she placed thousands of coronary stents.  Recognizing the need for a more comprehensive and holistic approach to cardiovascular disease, she founded the Scripps Center for Integrative Medicine and served as Medical Director for 15 years, where state-of-the-art cardiac imaging technology and lifestyle change programs could be used to aggressively diagnose, prevent and treat cardiovascular disease. She has served as a senior advisor for large healthcare systems to develop integrative medicine and wellness centers.

-           Evidence-based review of the efficacy of nutrition, lifestyle factors and nutraceuticals in the prevention and treatment of chronic diseases including diabetes, hypercholesterolemia, and atherosclerosis.

-           Evidence based review of stress, cortisol, DHEA and the microbiome.

-           Evidence based review of meditation and its effect on cardiovascular disease.


Friday, August 28, 2020: 7:00 – 8:00pm

Thyroid Hormone Deiodination and Its Clinical Implications

Antonio C. Bianco, MD, PhD

Antonio Bianco is a physician-scientist working in the thyroid field. His studies have focused on how the systemic hormone T3 initiates or terminates critical biological steps while maintaining relatively stable levels in the circulation. As a graduate student, he discovered the molecular link between deiodination and thermogenesis, specifically that the UCP-1 gene, key for brown adipose tissue thermogenesis, is transcriptionally stimulated by T3. This finding inspired further research on how deiodinases can modify intracellular T3 levels and signaling without antecedent changes in plasma TH levels. Over the years, the work in his lab has established the importance of “local” control of TH metabolism provided by deiodinases. From a broad perspective, this work has inspired the modern paradigm that deiodinases regulate thyroid hormone signaling on a tissue-specific basis, playing critical roles in human health and disease. He also served in different administrative capacities and as President of the American Thyroid Association (2015-16).

Course Objectives:

-           Review of Hypothalamus, pituitary, thyroid axis.

-           Evidence based review Dio2 gene polymorphism Thr92Ala

-           Evidence based review of treatments for hypothyroidism.

Friday, August 28, 2020: 8:00 – 9:00pm

Using Serum TSH as Biological Index of Thyroid Function

Antonio C. Bianco, MD, PhD

Course Objectives:

-           Review of Hypothalamus, pituitary, thyroid axis.

-           Evidence based review of treatments for hypothyroidism.

Register Now

Expand Your Practice With New Clinical Skills

What the Attendees Say

See All Testimonials


If you have a question or problem registering, please email or call toll-free 866-962-2276